As COVID completes its sixth year, official statistics obscure the scale of harm, while Long COVID and excess deaths reveal ...
Learn more about whether Twist Bioscience Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
About Invivyd Inc. Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm ...
FODMAP Everyday® on MSN
How long COVID may be affecting your gut health
Third in a series of articles on COVID-19 and its effects on the gut, this article will explore “Long COVID” (also called ...
This study systematically elucidates the drug resistance mechanisms of five highly pathogenic viruses, proposes five ...
Health and Me on MSN
WHO approves two COVID-19 rapid antigen tests, check the details here
SD Biosensor STANDARD Q and ACON Flowflex—after their earlier emergency use during the pandemic. The move confirms long-term ...
A fast-spreading H3N2 flu strain is driving an unusually intense early season in the U.S., with millions of illnesses and ...
The COVID-19 vaccination offers protective maternal and newborn health benefits for mothers who develop SARS-CoV-2 infection ...
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
Scientists used a clinical-grade gum in experiments to "substantially" lower viral loads of two herpes simplex viruses and ...
COVID booster vaccinations — both monovalent and bivalent — offer benefits in reducing the risk for severe outcomes of COVID among patients with autoimmune diseases, a US real-world study shows.
The 2024-2025 COVID-19 vaccines offered protection against COVID-19-associated ED and urgent care visits among pediatric populations in the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback